ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 1213–1224 of 2020 project topics
Congenital Anomalies of Kidney Gene Discovery
Using WES for identifying causative variants in CAKUT including ROBO2, GATA3, and novel genes in families with kidney and urinary tract malformations.
Genetic Basis of Rare Kidney Diseases Click to view more details →
Genetic Focal Segmental Glomerulosclerosis Testing
Developing FSGS gene panels including TRPC6, INF2, and ACTN4 for identifying genetic FSGS amenable to targeted therapy rather than immunosuppression.
Genetic Basis of Rare Kidney Diseases Click to view more details →
Alport Syndrome COL4A Mutation SaaS Diagnostic Platform
A cloud-based SaaS platform that sequences and interprets COL4A gene variants to enable rapid diagnosis of Alport syndrome across clinical laboratories. This subscription-based service generates recurring revenue while reducing diagnostic turnaround time from weeks to days for nephrology centers.
Genetic Basis of Rare Kidney Diseases Click to view more details →
IgA Nephropathy Genetic Risk Stratification Commercial Tool
A proprietary software tool that analyzes genetic predisposition markers associated with IgA nephropathy progression to enable patient risk classification and personalized treatment planning. This product creates new revenue streams through licensing to pharmaceutical companies developing targeted IgA nephropathy therapeutics.
Genetic Basis of Rare Kidney Diseases Click to view more details →
Polycystic Kidney Disease PKD1 PKD2 Testing Services
A specialized genetic testing service offering comprehensive PKD1 and PKD2 sequencing with detailed variant interpretation for autosomal dominant polycystic kidney disease diagnosis. This high-volume diagnostic service captures substantial market share from major clinical genetics labs while supporting family screening programs that drive repeat testing.
Genetic Basis of Rare Kidney Diseases Click to view more details →
Membranoproliferative Glomerulonephritis C3GN Gene Panel
A targeted commercial gene panel that identifies pathogenic variants in complement-related genes causing C3 glomerulopathy and membranoproliferative GN subtypes. This diagnostic panel generates direct testing revenue while enabling patient stratification for complement inhibitor therapies with growing pharmaceutical market opportunities.
Genetic Basis of Rare Kidney Diseases Click to view more details →
Thin Basement Membrane Disease COL4A3 Commercial Screening
A rapid commercial screening service using next-generation sequencing to identify COL4A3 mutations in patients with benign familial hematuria and thin basement membrane disease. This service creates revenue through high-throughput testing volume while establishing a patient registry for future therapeutic trials and biomarker studies.
Genetic Basis of Rare Kidney Diseases Click to view more details →
Nephrotic Syndrome NPHS1 NPHS2 Mutation Analysis Platform
An integrated bioinformatics platform that performs automated sequencing and clinical interpretation of NPHS1 and NPHS2 genes for steroid-resistant nephrotic syndrome diagnosis in pediatric populations. This platform generates recurring licensing revenue from hospital networks while enabling early genetic diagnosis to optimize treatment selection and prevent unnecessary immunosuppression.
Genetic Basis of Rare Kidney Diseases Click to view more details →
Hypertrophic Cardiomyopathy Gene Panel Testing
Developing comprehensive HCM gene panels covering MYBPC3, MYH7, TNNT2, and other sarcomere genes for molecular diagnosis and family cascade testing.
Genetic Basis of Cardiomyopathies Click to view more details →
Dilated Cardiomyopathy Genetic Etiology Analysis
Applying DCM gene panels and exome sequencing for identifying TTN, LMNA, SCN5A, and other causative variants in familial and sporadic DCM.
Genetic Basis of Cardiomyopathies Click to view more details →
Arrhythmogenic Cardiomyopathy Gene Testing
Characterizing PKP2, DSP, DSG2, and other desmosome gene variants causing ARVC/ARVD for molecular diagnosis and sudden death risk assessment.
Genetic Basis of Cardiomyopathies Click to view more details →
Genotype-Guided Risk Stratification in Cardiomyopathy
Developing genotype-specific risk models for predicting outcomes including sudden cardiac death risk in carriers of different cardiomyopathy gene variants.
Genetic Basis of Cardiomyopathies Click to view more details →